RXQ Compounding is an FDA Approved 503B Outsourcing Facility in Athens, Ohio. The company manufactures sterile and non-sterile medications, and formularies including products on the FDA shortlist. It is currently licensed to ship to 38 states and Washington, D.C., with licenses for other states on the horizon.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/24/18 | $3,600,000 |
Advantage Capital Partners | undisclosed |
